17647-39-1

Basic information

• Product Name: 5-Isoxazolecarboxylic acid, 4,5-dihydro-3-phenyl-, methyl ester
• CAS NO: 17647-39-1
• Molecular Formula: C11H11NO3
• Molecular Weight: 205.213
• Mol File: 17647-39-1.mol
• Article Data: 34

Chemical Properties

• CAS DataBase Reference: 5-Isoxazolecarboxylic acid, 4,5-dihydro-3-phenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Isoxazolecarboxylic acid, 4,5-dihydro-3-phenyl-, methyl ester(17647-39-1)
• EPA Substance Registry System: 5-Isoxazolecarboxylic acid, 4,5-dihydro-3-phenyl-, methyl ester(17647-39-1)

Safety Data

• Hazardous Substances Data: 17647-39-1(Hazardous Substances Data)

Upstream product

• 873-67-6 benzonitrile oxide 
• 292638-85-8 acrylic acid methyl ester 
• 67-56-1 methanol 
• 932-90-1 Benzaldoxime 
• 108-88-3 toluene 
• 186581-53-3 diazomethane 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 203320-01-8 methyl (E)-triphenylstannylacrylate 
• 698-16-8 benzohydroximoyl chloride 
• 82101-74-4 methyl (E/Z)-2-(tributylstannyl)acrylate 
• 124582-37-2 methyl 2-(tributylstannanyl)-2-propenoate 
• 20141-73-5 benzaldehyde oxime O-tributylstannyl ether 
• 932-90-1 syn-benzaldehyde oxime 

Downstream Products

• 1569-94-4 (3-phenyl-4,5-dihydro-isoxazol-5-yl)-methanol 
• 10313-27-6 5-phenyl-4,5-dihydroisoxazole-3-carboxylic acid 

Relevant articles and documents

A new route to nitrile oxides from primary alkylhalides for in situ dipolar cycloadditions

A new route to nitrile oxide preparation from primary alkylbromide, chloride, nitrite and their cycloadditions with olefins to form isoxazolines in a single pot are described.

Heteroannulation of Alkenes with Enynyl Benziodoxolones and Silver Nitrite Involving CC bond Oxidative Cleavage: Entry to 3-Aryl-?2-isoxazolines

A copper-catalyzed [2 + 2 + 1] heteroannulation of alkenes with enynyl benziodoxolones and AgNO2 involving oxidative cleavage of the CC bond promoted by cooperative Zn(OTf)2, KOAc, and 4 ? MS for producing 3-aryl δ2-isoxazolines is reported. Mechanistic s

BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF

The invention provides novel compounds having the general formula (I): (I) wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.